Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 182

Results For "LTI"

2105 News Found

Narayana Hrudayalaya to open a hospital in Punjab
Hospitals | December 05, 2021

Narayana Hrudayalaya to open a hospital in Punjab

The hospital is scheduled to open in 2024 with a bed capacity of 225


SPARC to licence Biomodifying’s IP
Biotech | December 05, 2021

SPARC to licence Biomodifying’s IP

SPARC will pay Biomodifying a percentage of payments received for sublicenses of the licensed IP


Motherhood Hospitals opens second center in Pune
News | December 05, 2021

Motherhood Hospitals opens second center in Pune

The first hospital in Kharadi launched three years ago has made a significant difference to women and children's health


Novartis showcases its attractive growth pipeline
News | December 03, 2021

Novartis showcases its attractive growth pipeline

Focused medicines company delivering strong operational performance. Building depth in five core therapeutic areas, strength in technology platforms, and a balanced geographic footprint


North America accounts for 50 % of generic pharma market
News | December 03, 2021

North America accounts for 50 % of generic pharma market

Going forward, the fastest-growing regions in the generic pharmaceuticals market will be South America and the Middle East, where growth will be at CAGRs of 10.1% and 9.4% respectively


GSK's antibody drug sotrovimab works against Omicron mutations
Biotech | December 02, 2021

GSK's antibody drug sotrovimab works against Omicron mutations

Preclinical data demonstrate sotrovimab, authorised in multiple countries around the world, retains activity against all tested variants of concern, including key mutations of Omicron


Lupin launches learning platform for medical students
News | November 30, 2021

Lupin launches learning platform for medical students

Sciflix is a special Initiative by Lupin to assist future pulmonologists in staying abreast of the latest medical advances relevant to their speciality


Covishield effectiveness during the second wave at 63 per cent
Public Health | November 30, 2021

Covishield effectiveness during the second wave at 63 per cent

Vaccine effectiveness of complete vaccination against the moderate-to-severe disease was at 81 per cent


Thermo Fisher Scientific’s new CRISPR Genome editing protein
Biotech | November 30, 2021

Thermo Fisher Scientific’s new CRISPR Genome editing protein

Growing CRISPR genome editing portfolio supports researchers on path to future therapeutic applications


Daiichi Sankyo initiates Phase 3 trial for Destiny-Breast11 neoadjuvant therapy
Biotech | November 30, 2021

Daiichi Sankyo initiates Phase 3 trial for Destiny-Breast11 neoadjuvant therapy

Destiny-Breast11 will evaluate Enhertu as a monotherapy or Enhertu followed by paclitaxel, trastuzumab and pertuzumab